Showing 1 - 20 results of 1,142 for search '"Journal for ImmunoTherapy of Cancer"', query time: 0.12s Refine Results
  1. 1
    Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy

    Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy by Chun-Yu Chen, Mohammed G Ghonime, Uksha Saini, Michael C Kelly, Justin C Roth, Pin-Yi Wang, Katherine Miller, Ilse Hernandez-Aguirre, Yeaseul Kim, Xiaokui Mo, Joseph R Stanek, Tim Cripe, Elaine Mardis, Kevin A Cassady

    Published 2021-10-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    SIGLEC11 promotes M2 macrophage polarization through AKT–mTOR signaling and facilitates the progression of gastric cancer

    SIGLEC11 promotes M2 macrophage polarization through AKT–mTOR signaling and facilitates the progression of gastric cancer by Chen Li, Yang Lu, Yihao Liu, Minmin Shi, Zhenggang Zhu, Jingxin Yin, Qimeng Shi, Da Fu, Zhenqiang Wang

    Published 2025-01-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade

    Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade by Samantha Carreiro, Christine Loh, Neelu Kaila, Fu-Shan Kuo, Scott Boiko, David N Ciccone, Joshua J McElwee, Peter J Tummino

    Published 2025-07-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    CAR-T cell therapy in developing countries: how long should we wait?

    CAR-T cell therapy in developing countries: how long should we wait? by Om P Kurmi, Ramila Shilpakar, Sanjivan Gautam, Balram Gautam, Sudhamshu K C

    Published 2024-12-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee

    Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee by Charlie Garnett-Benson, Sarah Warren, Anne Monette, Alexandra Snyder, Janis M Taube, J Carl Barrett, Kurt A Schalper, Brian Topp

    Published 2024-07-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study

    Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study by Brian J Czerniecki, Sungjune Kim, Loretta S Loftus, Roberto Díaz, Hatem Soliman, Ricardo L B Costa, Hyo S Han, Younchul Kim, Peter A Forsyth, Kamran A Ahmed, Min Hsuan Wang, Michelle DeJesus, John A Arrington, Aixa E Soyano, Avan J Armaghani, Marilin Rosa, Jimmy J Caudell, Arnold B Etame, Nam D Tran, Hsiang-Hsuan Michael Yu

    Published 2025-04-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts

    TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts by Mads Hald Andersen, Inés Lecoq, Evelina Martinenaite, Maria Perez-Penco, Lucia Lara de la Torre

    Published 2024-02-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies

    GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies by Paul M Sondel, Amy K Erbe, Daniel Martinez, Samantha N Buongervino, Kristopher R Bosse, Guillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, Doncho V Zhelev, Shakhnozakhon Sadirova, Anna M Giudice, Laura Garcia-Gerique, Dimiter S Dimitrov

    Published 2022-12-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Immunotherapy-based regimens for patients with EGFR-mutated non-small cell lung cancer who progressed on EGFR-TKI therapy

    Immunotherapy-based regimens for patients with EGFR-mutated non-small cell lung cancer who progressed on EGFR-TKI therapy by Ying Wu, Yan Ling, Bao-Dong Qin, Xiao-Dong Jiao, Ling-Yan Yuan, Yuan-Sheng Zang

    Published 2024-04-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer

    Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer by Yuan Li, Jian Zheng, Zhizhong Pan, Penghui Zhou, Guochen Liu, Wu Jiang, Pei-Rong Ding, Zexian Liu, Qiaoqi Sui, Dingxin Liu, Jinghua Tang, Lingheng Kong, Kai Han, Leen Liao, Qingjian Ou, Binyi Xiao, Yihong Ling, Jiewei Chen, Zhixiang Zuo

    Published 2021-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis

    Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis by Chien-Fu Hung, Ssu-Hsueh Tseng, Sung-Taek Park, Brandon Lam, Ya-Chea Tsai, Max A Cheng, Emily Farmer, Deyin Xing

    Published 2020-05-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Intratumoral microbiota predicts the response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer

    Intratumoral microbiota predicts the response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer by Kun Wang, Yuhong Huang, Hao Peng, Lu Yang, Yilin Chen, Teng Zhu, Liulu Zhang, Minyi Cheng, Cangui Wu, Peiyong Li, Minting Liang, Xiaoqi Zhang

    Published 2025-04-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors

    Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors by Yi-Chiu Kuo, Hao-Kang Li, Tai-Sheng Wu, Ying Ru, Chia-Yun Lee, Pei-Ju Leng, Yi-Chun Hsieh, Yun-Jung Chiang, Zih-Fei Cheng, Yan-Liang Lin, Shih-Chia Hsiao, Sai-Wen Tang

    Published 2025-07-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation

    The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation by Pedro J Romero, Pablo Umana, Christine Trumpfheller, Eva Sum, Moritz Rapp, Harald Dürr, Alekhya Mazumdar

    Published 2022-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer

    Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer by Makoto Ueno, Masafumi Ikeda, Do-Youn Oh, Masatoshi Kudo, Christoph Helwig, Changhoon Yoo, Hye Jin Choi, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Isabelle Dussault

    Published 2020-05-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Comment on “Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer”

    Comment on “Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cance... by Chenglong Wang, Shuai An, Fang-Tong Liu

    Published 2025-04-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity

    Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity by Daan F Boreel, Paul N Span, Johan Bussink

    Published 2021-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression

    CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression by Agapitos Patakas, Bochong Li, Naveen K Mehta, Kristan Meetze, Patrick A Baeuerle, Jennifer S Michaelson, Hannah M Findlay, Timothy B London

    Published 2023-08-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy

    LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy by Zhishui Chen, Gang Chen, Li Chen, Xiangli Zhao, Lingjuan Sun, Zhibo Ma, Xiaosheng Tan, Yuhao Tu, Jingzeng Wang, Peixiang Lan

    Published 2024-01-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Frizzled-7-targeting antibody-derived bifunctional protein retargets NK cells against triple-negative breast cancer cells via MICA-NKG2D axis

    Frizzled-7-targeting antibody-derived bifunctional protein retargets NK cells against triple-negative breast cancer cells via MICA-NKG2D axis by Lin Yang, Tong Wang, Wei Xie, Jin Wang, Jing Xu, Hao Yang, Gang Huang, Haiyan Xie, Xiaofei Zhang, Danfang Li, Xingxing Li, Qingqing Huang, Chenyue Wang, Lisha Wu, Shuyang Mao, Zitong Wang, Yuxia Liu

    Published 2025-02-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: